Aristopharma Ltd

News

 

Aristopharma has launched Dermocin Ointment for the topical treatment of MRSA infections, Impetigo & other primary and secondary skin infections.

Aristopharma has launched Dermocin Ointment for the topical treatment of MRSA infections, Impetigo & other primary and secondary skin infections. Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a pathogen causing significant morbidity in both the pediatric and adult populations. Skin infections with MRSA is very difficult to treat with conventional typical antibiotics. In Bangladesh indiscriminate and incomplete use of antibiotics made MRSA more alarming.
Mupirocin is a topical antibacterial, effectively treats MRSA infections, Impetigo & other primary and secondary skin infections. Its unique chemical structure and mechanism of action are unrelated to other known classes of antibacterial agents, which has made it to be free of cross-resistance and effective against MRSA. Dermocin also highly effective in treating MRSA burn wound infection and it has no systemic side effects. Dermocin is safe for children and pregnant women as it can be given from two months of age and it is a pregnancy category B drug. Dermocin is available in attractive lamitube and hence it is easy to use, easy to squeeze and less chance of product loss.